The Effects of Cognitive Enhancement Drug (Coluracetam) on Visual Perception, Abstract Reasoning, Pattern Recognition, Spatial Orientation, and Analytical Thinking: A Case Study

Abstract

New medications to treat cognitive disorders may improve cognition in healthy individuals. However, limited studies were conducted on its efficacy among individuals without cognitive deficiencies. Thus, this case study aimed to explore the effects of using a cognitive enhancement drug (Coluracetam) on visual perception, abstract reasoning, pattern recognition, spatial orientation, and analytical thinking in a healthy adult male for three months. This case study utilized a mixed-method case study design. Data on the case presentation, investigation, treatment, physical and mental effects experienced by the respondent with Coluracetam were gathered from the respondent through a face-to-face interview. To measure the respondent's visual perception, abstract reasoning, pattern recognition, spatial orientation, and analytical thinking, our case study used the Brain Metrics Initiative (BMI)™ IQ test. Moreover, the researchers collated the pretest and posttest data on the respondent's visual perception, abstract reasoning, pattern recognition, spatial orientation, and analytical thinking during the first week of the first month and in the third month of using Coluracetam. Data were statistically analyzed using IBM SPSS version 27. There was an increase in visual perception, abstract reasoning, pattern recognition, and analytical thinking scores in the posttest; however, there was a decrease in spatial orientation scores in the posttest result. The test of significant difference between the increase and decrease in the pre-post test scores on visual perception, abstract reasoning, pattern recognition, spatial orientation, and analytical thinking indicates a statistically insignificant result (t = -0.33, p = 0.75). On the contrary, our findings showed a significant relationship between the pretest and posttest scores on the five variables since the computed values indicate (R2 = 0.95, F = 61.98, p = 0.004).Our study provides evidence that there is no significant difference between the pre-post test results on visual perception, abstract reasoning, pattern recognition, spatial orientation, and analytical thinking but has a significant relationship between the five variables aforementioned after using the cognitive enhancement drug (Coluracetam) for three months.